Inventor · Irvine, CA, US

Joanne Wang

26Patents
7h-index
20Co-inventors
65Inventor score

Filing activity: Mar 13, 2009 → Jul 15, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8198034B2 Immuno-based botulinum toxin serotype A activity assays Physics 36 Active
US8618261B2 Immuno-based botulinum toxin serotype A activity assays Physics 24 Active
US8455203B2 Immuno-based retargeted endopeptidase activity assays Physics 16 Active
US9249216B2 Immuno-based botulinum toxin serotype A activity assays Physics 11 Active
US8361789B2 Cells useful for immuno-based Botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 11 Active
US8455213B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 10 Active
US8455247B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 9 Active
US8501469B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 5 Active
US8507271B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 5 Active
US8455248B2 Cells useful for immuno-based Botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 4 Active
US8476068B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 3 Active
US10703806B2 Immuno-based botulinum toxin serotype A activity assays Physics 3 Active
US10451621B2 Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A Physics 3 Active
US10345306B2 Immuno-based retargeted endopeptidase activity assays Physics 3 Active
US8691566B1 Cells useful for immuno-based botulinum toxin serotype a activity assays Emerging Cross-Sectional Technologies 3 Active
US10900967B2 Immuno-based retargeted endopeptidase activity assays Physics 2 Active
US9651553B2 Immuno-based retargeted endopeptidase activity assays Physics 2 Active
US9625447B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 2 Active
US8476069B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 1 Active
US8663983B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 0 Active
US8663982B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 0 Active
US8603813B2 Cells useful for immuno-based botulinum toxin serotype A activity assays Emerging Cross-Sectional Technologies 0 Active
US11332518B2 Immuno-based botulinum toxin serotype A activity assays Physics 0 Active
US11261240B2 Immuno-based botulinum toxin serotype A activity assays Physics 0 Active
US10912823B2 Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.